ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Peptide Forums (GHRH, Sermorelin, etc)
General Peptide Use & Information
A human trial of oral BPC-157 was quickly canceled
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="sammmy" data-source="post: 271919" data-attributes="member: 38594"><p>This thread is not about FDA or CDC approvals or what anyone thinks of their process.</p><p></p><p>I personally do not care if a drug is not FDA approved, as long as it has consistent research demonstrating that it is safe and effective. This is not the case of BPC-157. The "research" on BPC-157 appears inconsistent, contradictory, and frankly speaking manipulated.</p><p></p><p>This "research" is coming from Croatia and China, which we can guess are the main manufacturers and have financial interest to exaggerate the positive results and downplay the dangers, which they didn't even bother to investigate - not even a mice study on the possibility to enhance tumor metastases. First the "research" claimed it enhances VEGF because that speeds up wound healing, then another "research" claims it suppresses VEGF because otherwise that would lead to tumor metastases. So which one is it?</p><p></p><p>Medicine in Croatia and China is not under the jurisdiction of the US FDA and the studies there are not at all expensive to do - yet they are either missing or not finishing successfully. Case report studies do not require any funding, yet are missing on BPC-157.</p><p></p><p>Getting an US patent is obviously not that expensive either because BPC-157 has such patent in 2017 granted to a Slovenian company Diagen. The patent is for salts of BPC-157 that are stable at acidic pH (wasn't BPC-157 supposed to be stable since it is "natural part of gastric juice"???):</p><p></p><p>[URL unfurl="true"]https://patents.google.com/patent/WO2014142764A1/en[/URL]</p></blockquote><p></p>
[QUOTE="sammmy, post: 271919, member: 38594"] This thread is not about FDA or CDC approvals or what anyone thinks of their process. I personally do not care if a drug is not FDA approved, as long as it has consistent research demonstrating that it is safe and effective. This is not the case of BPC-157. The "research" on BPC-157 appears inconsistent, contradictory, and frankly speaking manipulated. This "research" is coming from Croatia and China, which we can guess are the main manufacturers and have financial interest to exaggerate the positive results and downplay the dangers, which they didn't even bother to investigate - not even a mice study on the possibility to enhance tumor metastases. First the "research" claimed it enhances VEGF because that speeds up wound healing, then another "research" claims it suppresses VEGF because otherwise that would lead to tumor metastases. So which one is it? Medicine in Croatia and China is not under the jurisdiction of the US FDA and the studies there are not at all expensive to do - yet they are either missing or not finishing successfully. Case report studies do not require any funding, yet are missing on BPC-157. Getting an US patent is obviously not that expensive either because BPC-157 has such patent in 2017 granted to a Slovenian company Diagen. The patent is for salts of BPC-157 that are stable at acidic pH (wasn't BPC-157 supposed to be stable since it is "natural part of gastric juice"???): [URL unfurl="true"]https://patents.google.com/patent/WO2014142764A1/en[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Peptide Forums (GHRH, Sermorelin, etc)
General Peptide Use & Information
A human trial of oral BPC-157 was quickly canceled
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top